| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |